Teradata faces rising competition as billings growth slows to 3.4 percent

Teradata (TDC) shares trade at $30.59, but analyst commentary highlights slowing growth and margin compression that raise concerns about the company's competitive position. While the stock has returned 17.6% over the last six months, outperforming the S&P 500's 12.8% gain in the same period, analysts point to fundamental weaknesses that suggest better opportunities exist elsewhere in the market.

The primary concern centers on billings, a non-GAAP metric often referred to as cash revenue because it reflects money collected from customers within a specific period. Unlike recognized revenue, which is spread over the length of a contract, billings provide a direct view of current cash inflows. Teradata's billings reached $367 million in the second quarter, with year-on-year growth averaging just 3.4% over the last four quarters. This sluggish performance indicates that increasing competition is making it difficult for the company to acquire and retain customers.

Profitability trends also warrant scrutiny. Analysts favor GAAP operating margin over adjusted profits because adjusted figures exclude stock-based compensation, a legitimate expense used to attract talent. GAAP operating margin offers a clearer picture of how much money a company retains after developing, marketing, and selling its products. Over the last two years, Teradata's operating margin decreased by 3.5 percentage points. Although the historical margin was healthy, the trailing 12-month operating margin now stands at 7.5%. Shareholders will likely demand improved profitability to justify their investment.

Free cash flow serves as another critical indicator, as it accounts for all operating and capital expenses, making it difficult to manipulate. Analyst consensus estimates suggest that Teradata's cash conversion will decline over the next year. The projected free cash flow margin is expected to drop from 43.4% for the last 12 months to 18.7%. This significant contraction in cash generation further underscores the pressure on the company's financial foundation.

Despite these headwinds, Teradata currently trades at 1.8 times forward price-to-sales. While this valuation may appear reasonable on its own, the shaky fundamentals present substantial downside risk. Analysts argue that companies addressing major business pain points offer more compelling value, leading them to recommend divesting from Teradata in favor of other opportunities, such as entrenched endpoint security platforms. The combination of slowing billings growth, compressing margins, and declining free cash flow suggests that the current stock price may not adequately compensate for the inherent risks.